Skip to content

MitraClip® After Surgical Mitral Valve Repair

MitraClip® for the Treatment of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02853955
Acronym
MVRepair
Enrollment
30
Registered
2016-08-03
Start date
2016-05-31
Completion date
2016-11-30
Last updated
2016-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Regurgitation

Brief summary

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.

Detailed description

In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.

Interventions

DEVICEPercutaneous edge-to-edge repair of the mitral valve

MitraClip in patients with recurrent MI after surgical mitral valve repair.

Sponsors

LMU Klinikum
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* All patients with recurrent mitral regurgitation treated with a MitraClip®.

Exclusion criteria

* Patient with endocarditis, * Patients with torn mitral valve ring.

Design outcomes

Primary

MeasureTime frameDescription
Survival1 year
MR (mitral regurgitation) grade after clip treatment1 yearScale 0-4

Secondary

MeasureTime frameDescription
Distance in 6 minute walk test at latest follow up1 year
LVEF (left ventricular ejection fraction) at latest follow up1 year
LVEDV (left ventricular enddiastolic volume) at latest follow up1 year
LVEDD (lef ventricular enddiastolic diameter) at latest follow up1 year
MR (mitral regurgitation) grade at latest follow up1 yearScale 0-4
Procedural complicationsindex procedure
Death, recurrent mitral regurgitation grade > 2, repeat intervention/operation of mitral valve1 yearcombined endpoint defined as freedom from each Event (death, MR grade \>2 or reintervention/Operation)
Clip success based on type of sMVRindex proceduresuccess defined as reduction of 1 MR grade (scale 0-4)
Mean mitral valve gradient1 year
NYHA status at latest follow up1 year

Countries

Germany

Contacts

Primary ContactDaniel Braun, MD
Daniel.Braun@med.uni-muenchen.de+49 89 4400
Backup ContactJörg Hausleiter, MD
Joerg.Hausleiter@med.uni-muenchen.de+49 89 4400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026